Simeon George, Director at CRISPR Therapeutics AG (CRSP), bought 1,979,624 shares at $52.03 ($103.0M) on 2025-07-16, disclosed to the SEC on 2025-07-17.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $52.03 | 6,510 | $339K | 0.3% |
| 2 | $52.03 | 6,510 | $339K | 0.3% |
| 3 | $52.03 | 22,319 | $1.2M | 1.1% |
| 4 | $52.03 | 22,319 | $1.2M | 1.1% |
| 5 | $52.03 | 960,983 | $50.0M | 48.5% |
| 6 | $52.03 | 960,983 |
| $50.0M |
| 48.5% |
| Total | $52.03 avg | 1,979,624 | $103.0M | 100% |
| Filing → |
| NKTX | BUY | 2022-04-29 | $20.0M | — | Filing → |
| DSGN | BUY | 2021-04-01 | $5.0M | — | Filing → |
| TPTX | BUY | 2020-05-26 | $5.0M | — | Filing → |